_lowenstein,
The algorithm for the calculations is based on input as follows:
1 solid tumor platform for all operable, inoperable, newly diagnosed and recurrent malignancies + up to 50% cure rate or more with adjuvants and combos = Lots of happy patients and investors with a few hallelujahs and praises to God mixed in with thanks to Dr. Linda Liau, Dr. Ashkan and the folks at NWBO mixed in. The dollar amount keeps changing based on informed investors count which is expected to rise logarithmically but when averaged back to current discounted rate the price sits at just a little under $200 ; ). Best wishes.